glutathione parkinson's disease therapy for Parkinson's Disease Treatment | IV

Rapidly progressing maculopathy with severe photoreceptor and ganglion cell loss, renal thrombotic microangiopathy, hemolytic uremic syndrome, pulmonary hypertension, and pulmonary thrombotic events have also been described in adult-onset cobalamin C defect (42

doi:10.1016/j.exer.2006.10.008

The authors stated that the peptide had the effect of increasing melatonin concentration in the test subjects, thus contributing to enhanced control of the sleepwake cycle [6]

Safety Takeaway: While the evidence from controlled human trials suggests a manageable adverse event profile, the products full extent of long-term safety, especially regarding chronic and rare side effects, remains undetermined until the completion of ongoing large-scale clinical programs and subsequent regulatory review and approval

I also know people that are taking oral versions of this and I think that science has shown that thats completely useless